Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
003015.SZ Stock Summary
Top 10 Correlated ETFs
003015.SZ
In the News
003015.SZ Financial details
Company Rating
Buy
Market Cap
3.27B
Income
8.39M
Revenue
463.4M
Book val./share
3.69
Cash/share
0.69
Dividend
0.2
Dividend %
1.63%
Employees
486
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
433.37
Forward P/E
-
PEG
-48.41
P/S
9.21
P/B
3.63
P/C
18.86
P/FCF
-182.77
Quick Ratio
1.35
Current Ratio
1.95
Debt / Equity
0.16
LT Debt / Equity
0
-
-
EPS (TTM)
0.03
EPS next Y
-
EPS next Q
-
EPS this Y
-48.28%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-17.4%
Revenue last 5Y
0.15%
Revenue Q/Q
14.28%
EPS Q/Q
-74.52%
-
-
-
-
SMA20
33.33%
SMA50
-7.69%
SMA100
20%
Inst Own
-
Inst Trans
-
ROA
1%
ROE
1%
ROC
0.01%
Gross Margin
24%
Oper. Margin
3%
Profit Margin
2%
Payout
695%
Shs Outstand
271.52M
Shs Float
186.31M
-
-
-
-
Target Price
-
52W Range
6.58-17.1
52W High
-23.47%
52W Low
+116.83%
RSI
63
Rel Volume
1.44
Avg Volume
42.55M
Volume
61.25M
Perf Week
9.33%
Perf Month
91.04%
Perf Quarter
-
Perf Half Y
3.09%
-
-
-
-
Beta
0.474
-
-
Volatility
0.52%, 1.46%
Prev Close
4.83%
Price
13.01
Change
6.9%
003015.SZ Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 2.35 | 2.6 | 2.35 | 1.76 | 1.76 | |
Net income per share | 0.39 | 0.4 | 0.45 | 0.3 | 0.15 | |
Operating cash flow per share | 0.43 | 0.38 | 0.51 | 0.58 | 0.75 | |
Free cash flow per share | -0.34 | -0.51 | 0.28 | -0.29 | 0.03 | |
Cash per share | 0.31 | 0.53 | 2.3 | 0.96 | 0.56 | |
Book value per share | 2.67 | 2.9 | 5.12 | 4.04 | 3.95 | |
Tangible book value per share | 2.47 | 2.71 | 4.95 | 3.91 | 3.82 | |
Share holders equity per share | 2.67 | 2.9 | 5.12 | 4.04 | 3.95 | |
Interest debt per share | 0.59 | 1.29 | 0.91 | 0.48 | 0.44 | |
Market cap | 1.87B | 2.01B | 3.28B | 3.22B | 2.28B | |
Enterprise value | 1.92B | 2.15B | 2.96B | 3.08B | 2.25B | |
P/E ratio | 24.26 | 23.65 | 33.13 | 39.12 | 57.27 | |
Price to sales ratio | 4.02 | 3.64 | 6.35 | 6.6 | 4.87 | |
POCF ratio | 21.81 | 24.86 | 29.25 | 19.97 | 11.42 | |
PFCF ratio | -27.85 | -18.48 | 54.21 | -39.74 | 275.23 | |
P/B Ratio | 3.54 | 3.27 | 2.91 | 2.88 | 2.17 | |
PTB ratio | 3.54 | 3.27 | 2.91 | 2.88 | 2.17 | |
EV to sales | 4.12 | 3.91 | 5.73 | 6.31 | 4.79 | |
Enterprise value over EBITDA | 13.55 | 13.07 | 15.82 | 17.63 | 16.99 | |
EV to operating cash flow | 22.31 | 26.67 | 26.41 | 19.1 | 11.23 | |
EV to free cash flow | -28.49 | -19.82 | 48.94 | -38 | 270.67 | |
Earnings yield | 0.04 | 0.04 | 0.03 | 0.03 | 0.02 | |
Free cash flow yield | -0.04 | -0.05 | 0.02 | -0.03 | 0 | |
Debt to equity | 0.2 | 0.42 | 0.17 | 0.11 | 0.11 | |
Debt to assets | 0.15 | 0.26 | 0.13 | 0.09 | 0.09 | |
Net debt to EBITDA | 0.31 | 0.89 | -1.7 | -0.81 | -0.29 | |
Current ratio | 2.05 | 1.57 | 3.88 | 3.91 | 2.23 | |
Interest coverage | 8.34 | 6.27 | 9.62 | 12.67 | 13.29 | |
Income quality | 1.11 | 0.95 | 1.13 | 1.96 | 5.01 | |
Dividend Yield | 0.02 | 0.01 | 0 | 0.02 | 0.03 | |
Payout ratio | 0.43 | 0.16 | 0.12 | 0.6 | 1.49 | |
Sales general and administrative to revenue | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | |
Research and developement to revenue | 0.04 | 0.04 | 0.05 | 0.05 | 0.05 | |
Intangibles to total assets | 0.06 | 0.04 | 0.03 | 0.03 | 0.03 | |
Capex to operating cash flow | -1.78 | -2.35 | -0.46 | -1.5 | -0.96 | |
Capex to revenue | -0.33 | -0.34 | -0.1 | -0.5 | -0.41 | |
Capex to depreciation | -4.61 | -4.79 | -0.9 | -4 | -2.83 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 4.84 | 5.1 | 7.2 | 5.2 | 3.65 | |
ROIC | 0.12 | 0.09 | 0.07 | 0.07 | 0.05 | |
Return on tangible assets | 0.11 | 0.09 | 0.07 | 0.06 | 0.03 | |
Graham Net | 0.27 | -0.24 | 2.18 | 1.07 | 0.43 | |
Working capital | 184.92M | 170.76M | 687.45M | 504.64M | 275.9M | |
Tangible asset value | 490.11M | 575.7M | 1.09B | 1.08B | 1.02B | |
Net current asset value | 172.08M | 84.49M | 616.18M | 453.95M | 242.54M | |
Invested capital | 0.2 | 0.42 | 0.17 | 0.11 | 0.11 | |
Average receivables | 84.11M | 202.7M | 268.93M | 274.33M | 222.36M | |
Average payables | 59.74M | 77.77M | 76.55M | 54.23M | 73.63M | |
Average inventory | 100.38M | 99.65M | 103.27M | 125.68M | 141.74M | |
Days sales outstanding | 131.87 | 157.04 | 212.14 | 185.35 | 153.06 | |
Days payables outstanding | 72.65 | 97.36 | 67.09 | 58.9 | 105.61 | |
Days of inventory on hand | 128.04 | 94.85 | 131.51 | 160.86 | 159.17 | |
Receivables turnover | 2.77 | 2.32 | 1.72 | 1.97 | 2.38 | |
Payables turnover | 5.02 | 3.75 | 5.44 | 6.2 | 3.46 | |
Inventory turnover | 2.85 | 3.85 | 2.78 | 2.27 | 2.29 | |
ROE | 0.15 | 0.14 | 0.09 | 0.07 | 0.04 | |
Capex per share | -0.77 | -0.89 | -0.23 | -0.88 | -0.72 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.43 | 0.43 | 0.3 | 0.39 | 0.51 | |
Net income per share | 0.02 | 0.02 | -0.02 | 0.03 | 0.01 | |
Operating cash flow per share | 0.02 | 0.02 | -0.02 | 0.11 | 0.04 | |
Free cash flow per share | -0.14 | -0.1 | -0.03 | 0.01 | 0.03 | |
Cash per share | 0.52 | 0.59 | 0.56 | 0.45 | 0.69 | |
Book value per share | 4.01 | 4.16 | 3.37 | 3.22 | 3.69 | |
Tangible book value per share | 3.87 | 4.02 | 3.25 | 3.1 | 3.56 | |
Share holders equity per share | 4.01 | 4.16 | 3.37 | 3.22 | 3.69 | |
Interest debt per share | 0.44 | 0.45 | 0.37 | 0.4 | 0.6 | |
Market cap | 2.16B | 2.17B | 3.01B | 2.94B | 3.05B | |
Enterprise value | 2.13B | 2.13B | 2.97B | 2.94B | 3.06B | |
P/E ratio | 103.08 | 114.31 | -121.25 | 91.39 | 422.55 | |
Price to sales ratio | 19.17 | 20.12 | 32.2 | 24.04 | 21.84 | |
POCF ratio | 412.34 | 457.23 | -485 | 88.83 | 265.71 | |
PFCF ratio | -57.22 | -88.34 | -303.4 | 848.36 | 396.31 | |
P/B Ratio | 2.06 | 2.07 | 2.88 | 2.94 | 3.05 | |
PTB ratio | 2.06 | 2.07 | 2.88 | 2.94 | 3.05 | |
EV to sales | 18.96 | 19.77 | 31.77 | 24.05 | 21.93 | |
Enterprise value over EBITDA | 265.66 | 165.25 | -1.4K | 176.23 | 358.93 | |
EV to operating cash flow | 407.89 | 449.25 | -478.61 | 88.88 | 266.83 | |
EV to free cash flow | -56.61 | -86.8 | -299.4 | 848.84 | 397.98 | |
Earnings yield | 0 | 0 | 0 | 0 | 0 | |
Free cash flow yield | -0.02 | -0.01 | 0 | 0 | 0 | |
Debt to equity | 0.11 | 0.11 | 0.11 | 0.12 | 0.16 | |
Debt to assets | 0.09 | 0.09 | 0.09 | 0.1 | 0.12 | |
Net debt to EBITDA | -2.9 | -2.93 | 18.71 | 0.1 | 1.5 | |
Current ratio | 2.21 | 2.23 | 2.27 | 2.04 | 1.95 | |
Interest coverage | 7.27 | 5.42 | -5.27 | 10.37 | 3.24 | |
Income quality | 1 | 1 | 1 | 4.12 | 6.36 | |
Dividend Yield | 0 | 0 | 0 | 0.02 | 0 | |
Payout ratio | 0.21 | 0.23 | -0.16 | 6.87 | 0.58 | |
Sales general and administrative to revenue | 0.18 | -0.14 | 0.12 | -0.05 | 0.16 | |
Research and developement to revenue | 0.07 | 0.05 | 0.07 | 0.06 | 0.06 | |
Intangibles to total assets | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | |
Capex to operating cash flow | -8.21 | -6.18 | 0.6 | -0.9 | -0.33 | |
Capex to revenue | -0.38 | -0.27 | -0.04 | -0.24 | -0.03 | |
Capex to depreciation | -2.28 | -1.56 | -0.15 | -1.23 | 0.08 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 1.34 | 1.33 | 1.23 | 1.37 | 0.74 | |
ROIC | 0 | 0 | -0.01 | 0.01 | 0 | |
Return on tangible assets | 0 | 0 | 0 | 0.01 | 0 | |
Graham Net | 0.38 | 0.45 | 0.4 | 0.32 | 0.42 | |
Working capital | 273.54M | 275.9M | 286.58M | 248.7M | 265.98M | |
Tangible asset value | 1.01B | 1.02B | 1.01B | 963.23M | 965.28M | |
Net current asset value | 228.66M | 242.54M | 253.75M | 231.03M | 246.98M | |
Invested capital | 0.11 | 0.11 | 0.11 | 0.12 | 0.16 | |
Average receivables | 231.95M | 209.33M | 187.02M | 176.44M | 184.4M | |
Average payables | 116.62M | 100.87M | 101.62M | 96.14M | 86.2M | |
Average inventory | 132.87M | 141.35M | 151.06M | 161.05M | 164.12M | |
Days sales outstanding | 177.51 | 164.06 | 170.68 | 129.25 | 124.46 | |
Days payables outstanding | 114.33 | 105.49 | 128.35 | 89.91 | 71.52 | |
Days of inventory on hand | 149.02 | 158.98 | 188.37 | 173.67 | 134.19 | |
Receivables turnover | 0.51 | 0.55 | 0.53 | 0.7 | 0.72 | |
Payables turnover | 0.79 | 0.85 | 0.7 | 1 | 1.26 | |
Inventory turnover | 0.6 | 0.57 | 0.48 | 0.52 | 0.67 | |
ROE | 0 | 0 | -0.01 | 0.01 | 0 | |
Capex per share | -0.16 | -0.12 | -0.01 | -0.1 | -0.01 |
003015.SZ Frequently Asked Questions
What is Jiangsu Rijiu Optoelectronics Jointstock Co., Ltd stock symbol ?
Jiangsu Rijiu Optoelectronics Jointstock Co., Ltd is a CN stock and trading under the symbol 003015.SZ
What is Jiangsu Rijiu Optoelectronics Jointstock Co., Ltd stock quote today ?
Jiangsu Rijiu Optoelectronics Jointstock Co., Ltd stock price is $13.01 today.
Is Jiangsu Rijiu Optoelectronics Jointstock Co., Ltd stock public?
Yes, Jiangsu Rijiu Optoelectronics Jointstock Co., Ltd is a publicly traded company.